This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Quality of Care  • Patient Safety/ Medical Error  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2009;302(16):1743.

	Since this article does not have an abstract, we have provided the first 111 words of the full text and any section headings.

On the heels of controversy surrounding the US Food and Drug Administration's premarket reviews of medical devices, the agency has commissioned an Institute of Medicine review of its premarket oversight of devices, also called the 510(k) process.

The IOM will conduct 2 public workshops during the next 9 months as part of its review, and will publish its findings in March 2011. In the meantime, the FDA's Center for Devices and Radiological Health will conduct an internal review and work to improve the consistency of the 510(k) process, according to a statement from the agency.

More information about the FDA's oversight of devices is available at http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/PremarketNotification510k/default.htm.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?